According to Savara Pharmaceuticals's latest financial reports the company has $0.12 B in net assets.
A companyโs net assets is the sum of its assets minus the sum of its liabilities.
Year | Net assets | Change |
---|---|---|
2023-12-31 | $0.14 B | 30.24% |
2022-12-31 | $0.10 B | -25.41% |
2021-12-31 | $0.14 B | 124.44% |
2020-12-31 | $64.38 M | -36.69% |
2019-12-31 | $0.10 B | -6.03% |
2018-12-31 | $0.10 B | -9.3% |
2017-12-31 | $0.11 B | -432.57% |
2016-12-31 | $-35.88 M | -250.17% |
2015-12-31 | $23.88 M | -59.27% |
2014-12-31 | $58.65 M | 22.69% |
2013-12-31 | $47.8 M | 14.39% |
2012-12-31 | $41.79 M | -26.39% |
2011-12-31 | $56.77 M | 112.77% |
2010-12-31 | $26.68 M | 299.87% |
2009-12-31 | $6.67 M | 11.31% |
2008-12-31 | $5.99 M | -80.68% |
2007-12-31 | $31.03 M | -38.32% |
2006-12-31 | $50.31 M | -742.7% |
2005-12-31 | $-7.83 M | -163.18% |
2004-12-31 | $12.39 M | 200.71% |
2003-12-31 | $4.12 M | -583.19% |
2002-12-31 | $-0.86 M | 33.56% |
2001-12-31 | $-0.64 M |
Company | Net assets | differencediff. | Country |
---|---|---|---|
OPKO Health
OPK | $1.25 B | 928.06% | ๐บ๐ธ USA |
Onconova Therapeutics ONTX | $6.01 M | -95.06% | ๐บ๐ธ USA |